Daclizumab acts through ?
Ans. is 'c' i.e., IL 2 receptor blocker Monoclonal antibodies (daclizumab and basiliximab) that block the interleukin 2 receptor and are used in prevention of graft rejection as immunosuppresant.
cGMP activation
Adenylcyclase inhibition
IL 2 receptor blocker
IL10 receptor blocker